Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB

Saved in:
Bibliographic Details
Published in:Pulmonology 2024-03, Vol.30 (2), p.184-187
Main Authors: Oehadian, A., Bastos, M.L., Centis, R., D'Ambrosio, L., Migliori, G.B., Santoso, P., Ruslami, R., Menzies, D.
Format: Article
Language:English
Subjects:
Antitubercular Agents - adverse effects
Humans
Linezolid - adverse effects
Tuberculosis, Multidrug-Resistant - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c357t-8ad69604784d088167b2e54eee984727598b2da1ccb615b97d3f8bbc7d16981a3
container_end_page 187
container_issue 2
container_start_page 184
container_title Pulmonology
container_volume 30
creator Oehadian, A.
Bastos, M.L.
Centis, R.
D'Ambrosio, L.
Migliori, G.B.
Santoso, P.
Ruslami, R.
Menzies, D.
description
doi_str_mv 10.1016/j.pulmoe.2023.09.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2872181167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2531043723001678</els_id><sourcerecordid>2872181167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-8ad69604784d088167b2e54eee984727598b2da1ccb615b97d3f8bbc7d16981a3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoKuo_EMnRS2s-2ia9CH4rrAii55Ams5ilbWqSruivt-uqeBIGZg7PO8M8CB1SklNCq5NFPoxt5yFnhPGc1DkhfAPtspLTjBRcbP6Zd9BBjAtCCJuKS7qNdrgQklcF2UX9gzFjCNAbwLq3eAhgnUk-ROznWNslhAgYltCniHWM3jidwOI3l17wzPXw4VtnsetxegGcAujUTewqPOjkvmJf7P3lY_Z0vo-25rqNcPDd99Dz9dXTxW02e7i5uzibZYaXImVS26quSCFkYYmUtBINg7IAgFoWgomylg2zmhrTVLRsamH5XDaNEZZWtaSa76Hj9d4h-NcRYlKdiwbaVvfgx6iYFIxKOi2e0GKNmuBjDDBXQ3CdDu-KErWSrRZqLVutZCtSq0n2FDv6vjA2Hdjf0I_aCThdAzD9uXQQVDRu5dm6ACYp693_Fz4BFHaSoA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2872181167</pqid></control><display><type>article</type><title>Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB</title><source>ScienceDirect</source><creator>Oehadian, A. ; Bastos, M.L. ; Centis, R. ; D'Ambrosio, L. ; Migliori, G.B. ; Santoso, P. ; Ruslami, R. ; Menzies, D.</creator><creatorcontrib>Oehadian, A. ; Bastos, M.L. ; Centis, R. ; D'Ambrosio, L. ; Migliori, G.B. ; Santoso, P. ; Ruslami, R. ; Menzies, D.</creatorcontrib><identifier>ISSN: 2531-0437</identifier><identifier>EISSN: 2531-0437</identifier><identifier>DOI: 10.1016/j.pulmoe.2023.09.003</identifier><identifier>PMID: 37783640</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Antitubercular Agents - adverse effects ; Humans ; Linezolid - adverse effects ; Tuberculosis, Multidrug-Resistant - drug therapy</subject><ispartof>Pulmonology, 2024-03, Vol.30 (2), p.184-187</ispartof><rights>2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c357t-8ad69604784d088167b2e54eee984727598b2da1ccb615b97d3f8bbc7d16981a3</cites><orcidid>0000-0002-7182-386X ; 0000-0002-2597-574X ; 0000-0003-4995-5054 ; 0000-0002-7853-2221</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2531043723001678$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37783640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oehadian, A.</creatorcontrib><creatorcontrib>Bastos, M.L.</creatorcontrib><creatorcontrib>Centis, R.</creatorcontrib><creatorcontrib>D'Ambrosio, L.</creatorcontrib><creatorcontrib>Migliori, G.B.</creatorcontrib><creatorcontrib>Santoso, P.</creatorcontrib><creatorcontrib>Ruslami, R.</creatorcontrib><creatorcontrib>Menzies, D.</creatorcontrib><title>Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB</title><title>Pulmonology</title><addtitle>Pulmonology</addtitle><subject>Antitubercular Agents - adverse effects</subject><subject>Humans</subject><subject>Linezolid - adverse effects</subject><subject>Tuberculosis, Multidrug-Resistant - drug therapy</subject><issn>2531-0437</issn><issn>2531-0437</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMoKuo_EMnRS2s-2ia9CH4rrAii55Ams5ilbWqSruivt-uqeBIGZg7PO8M8CB1SklNCq5NFPoxt5yFnhPGc1DkhfAPtspLTjBRcbP6Zd9BBjAtCCJuKS7qNdrgQklcF2UX9gzFjCNAbwLq3eAhgnUk-ROznWNslhAgYltCniHWM3jidwOI3l17wzPXw4VtnsetxegGcAujUTewqPOjkvmJf7P3lY_Z0vo-25rqNcPDd99Dz9dXTxW02e7i5uzibZYaXImVS26quSCFkYYmUtBINg7IAgFoWgomylg2zmhrTVLRsamH5XDaNEZZWtaSa76Hj9d4h-NcRYlKdiwbaVvfgx6iYFIxKOi2e0GKNmuBjDDBXQ3CdDu-KErWSrRZqLVutZCtSq0n2FDv6vjA2Hdjf0I_aCThdAzD9uXQQVDRu5dm6ACYp693_Fz4BFHaSoA</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Oehadian, A.</creator><creator>Bastos, M.L.</creator><creator>Centis, R.</creator><creator>D'Ambrosio, L.</creator><creator>Migliori, G.B.</creator><creator>Santoso, P.</creator><creator>Ruslami, R.</creator><creator>Menzies, D.</creator><general>Elsevier España, S.L.U</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7182-386X</orcidid><orcidid>https://orcid.org/0000-0002-2597-574X</orcidid><orcidid>https://orcid.org/0000-0003-4995-5054</orcidid><orcidid>https://orcid.org/0000-0002-7853-2221</orcidid></search><sort><creationdate>202403</creationdate><title>Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB</title><author>Oehadian, A. ; Bastos, M.L. ; Centis, R. ; D'Ambrosio, L. ; Migliori, G.B. ; Santoso, P. ; Ruslami, R. ; Menzies, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-8ad69604784d088167b2e54eee984727598b2da1ccb615b97d3f8bbc7d16981a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antitubercular Agents - adverse effects</topic><topic>Humans</topic><topic>Linezolid - adverse effects</topic><topic>Tuberculosis, Multidrug-Resistant - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oehadian, A.</creatorcontrib><creatorcontrib>Bastos, M.L.</creatorcontrib><creatorcontrib>Centis, R.</creatorcontrib><creatorcontrib>D'Ambrosio, L.</creatorcontrib><creatorcontrib>Migliori, G.B.</creatorcontrib><creatorcontrib>Santoso, P.</creatorcontrib><creatorcontrib>Ruslami, R.</creatorcontrib><creatorcontrib>Menzies, D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oehadian, A.</au><au>Bastos, M.L.</au><au>Centis, R.</au><au>D'Ambrosio, L.</au><au>Migliori, G.B.</au><au>Santoso, P.</au><au>Ruslami, R.</au><au>Menzies, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB</atitle><jtitle>Pulmonology</jtitle><addtitle>Pulmonology</addtitle><date>2024-03</date><risdate>2024</risdate><volume>30</volume><issue>2</issue><spage>184</spage><epage>187</epage><pages>184-187</pages><issn>2531-0437</issn><eissn>2531-0437</eissn><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>37783640</pmid><doi>10.1016/j.pulmoe.2023.09.003</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7182-386X</orcidid><orcidid>https://orcid.org/0000-0002-2597-574X</orcidid><orcidid>https://orcid.org/0000-0003-4995-5054</orcidid><orcidid>https://orcid.org/0000-0002-7853-2221</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2531-0437
ispartof Pulmonology, 2024-03, Vol.30 (2), p.184-187
issn 2531-0437
2531-0437
language eng
recordid cdi_proquest_miscellaneous_2872181167
source ScienceDirect
subjects Antitubercular Agents - adverse effects
Humans
Linezolid - adverse effects
Tuberculosis, Multidrug-Resistant - drug therapy
title Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A48%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Occurrence%20and%20predictors%20of%20adverse%20events%20associated%20with%20Linezolid%20in%20the%20treatment%20of%20patients%20with%20MDR-TB&rft.jtitle=Pulmonology&rft.au=Oehadian,%20A.&rft.date=2024-03&rft.volume=30&rft.issue=2&rft.spage=184&rft.epage=187&rft.pages=184-187&rft.issn=2531-0437&rft.eissn=2531-0437&rft_id=info:doi/10.1016/j.pulmoe.2023.09.003&rft_dat=%3Cproquest_cross%3E2872181167%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-8ad69604784d088167b2e54eee984727598b2da1ccb615b97d3f8bbc7d16981a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2872181167&rft_id=info:pmid/37783640&rfr_iscdi=true